(S1 (S (NP (NP (NN Akt)) (, ,) (NP (NN NFkappaB)) (, ,) (CC and) (NP (NN Stat3) (NN Signaling))) (VP (VBP Are) (VP (VBN Required) (PP (IN for) (NP (NP (DT the) (NP (NP (NN Growth)) (CC and) (NP (NN Survival)))) (PP (IN of) (NP (NN Lymphoma) (NNS Cells)))))))))
(S1 (S (NP (NP (NN MTS) (NN assay)) (PP (IN of) (NP (NP (NNS splenocytes)) (PP (IN from) (NP (NP (ADJP (PRN (-LRB- -LRB-) (NP (NP (NN A)) (CC and) (NP (NN B))) (-RRB- -RRB-)) (ADJP (JJ WT)) (CC or) (PRN (-LRB- -LRB-) (NP (NP (NN C)) (CC and) (NP (NN D))) (-RRB- -RRB-))) (NN LMP1) (JJ transgenic) (NNS lymphomas)) (CC and) (NP (-LRB- -LRB-) (NP (NP (NN E)) (CC and) (NP (NN F))) (-RRB- -RRB-) (NN LMP1) (JJ transgenic) (NNS lymphoctyes)))))) (. .))))
(S1 (S (S (NP (NNS Splenocytes)) (VP (VBD were) (VP (VBN cultured) (PP (IN with) (CC or) (PP (IN without) (NP (NP (NNS inhibitors)) (PP (IN of) (NP (NP (NP (NN NFkappaB)) (PRN (-LRB- -LRB-) (NP (NN BAY11)) (-RRB- -RRB-))) (, ,) (NP (NP (NN mTOR)) (PRN (-LRB- -LRB-) (NP (NN rapamycin)) (-RRB- -RRB-))) (, ,) (NP (NP (NN Akt)) (PRN (-LRB- -LRB-) (NP (NN triciribine)) (-RRB- -RRB-))) (, ,) (NP (NP (NN MEK1/2)) (PRN (-LRB- -LRB-) (NP (NN U0126)) (-RRB- -RRB-))) (, ,) (NP (NP (NN p38)) (PRN (-LRB- -LRB-) (NP (NN SB202190)) (-RRB- -RRB-))) (, ,) (CC or) (NP (NP (NN Stat3)) (PRN (-LRB- -LRB-) (NP (NN cucurbitacin) (CD I) (CC and) (CD AG490)) (-RRB- -RRB-)))))))) (PP (IN at) (NP (DT the) (VBN indicated) (NNS concentrations)))))) (. .)))
(S1 (S (S (NP (DT The) (NNS results)) (VP (VBP are) (NP (NP (DT the) (NP (NN mean)) (CC +/-) (NP (NN SEM))) (PP (IN of) (NP (JJ triplicate) (NNS samples)))))) (. .)))
(S1 (S (S (NP (VBN Shown)) (VP (VBP are) (NP (NP (DT the) (NNS results)) (PP (IN for) (NP (NP (-LRB- -LRB-) (NP (NP (NN A)) (CC and) (NP (NN B))) (-RRB- -RRB-) (JJ WT) (NN lymphoma) (CD 1)) (, ,) (NP (PRN (-LRB- -LRB-) (NP (NP (NN C)) (CC and) (NP (NN D))) (-RRB- -RRB-)) (NP (NN LMP1) (JJ transgenic) (NN lymphoma) (CD 2))) (, ,) (CC and) (NP (PRN (-LRB- -LRB-) (NP (NP (NN E)) (CC and) (NP (NN F))) (-RRB- -RRB-)) (NP (CD one)) (PP (IN out) (IN of) (NP (NP (CD two) (NN LMP1) (JJ transgenic) (NNS mice)) (VP (VBN analyzed)))))))))) (. .)))
(S1 (S (S (NP (DT This) (NN analysis)) (VP (VBD was) (VP (VBN repeated) (PP (IN with) (NP (NP (NN LMP1) (JJ transgenic) (NN lymphoma) (CD 4)) (VP (VBG yielding) (NP (JJ similar) (NNS results)))))))) (. .)))
